Unknown PHASE2 INTERVENTIONAL NCT01039181

Calcitriol in Advanced Intrahepatic Cholangiocarcinoma

A Clinical Trial Phase II of Calcitriol in Combination With 5-fluorouracil, Mitomycin C and Leucovorin in an Open Label-non-randomized Study to Evaluate the Tumor Response in Patients With Advanced Intrahepatic Cholangiocarcinoma

Sponsor: Khon Kaen University

Conditions Advanced Intrahepatic Cholangiocarcinoma

Interventions Calcitriol

Updated 5 times since 2017 Last updated: Dec 23, 2009 Started: Jan 31, 2010 Primary completion: Oct 31, 2011 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01039181, this PHASE2 trial focuses on Advanced Intrahepatic Cholangiocarcinoma and remains ongoing. Sponsored by Khon Kaen University, it has been updated 5 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Khon Kaen University
National Science and Technology Development Agency, Thailand

Data source: National Science and Technology Development Agency, Thailand

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Khon Kaen, Thailand